Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis
Edward Christopher Dee, Mathieu Laversanne, Nirmala Bhoo-Pathy Lancet Oncol. 2025 Apr;26(4):516-528
Cancer is a
leading cause of morbidity and mortality in southeast Asia. We aimed to present
and interpret cancer incidence and mortality statistics in the 11 constituent
countries of Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines,
Singapore, Thailand, Timor-Leste, and Viet Nam to inform research priorities,
health services, and cancer policy. For the
11 countries in southeast Asia for all cancers combined, 545 725 (47·6%) of a
total of 1,146 810 incident cases were estimated in men and 601 085 (52·4%)
incident cases were estimated in women in 2022. In the same period, 385 430
(53·8%) of a total of 716 116 deaths were estimated in men and 330 686 (46·2%)
deaths were estimated in women. The total cancer ASIR in men and women was
highest in Singapore (235·89 per 100 000 and 231·01 per 100 000 respectively),
while the corresponding ASMR was greatest in Laos for men (132·91 per 100 000)
and Brunei for women (104·20 per 100 000). Breast cancer was the most common
cancer among women in all countries and the Philippines and the most common
cause of cancer mortality among women in the Philippines, Malaysia, Singapore, Viet
Nam, Indonesia, and Timor-Leste. Among men, lung cancer was the most frequently
diagnosed cancer in the Philippines, Malaysia, Myanmar, and Indonesia and the
leading cause of death due to cancer in the Philippines, Singapore, Brunei,
Malaysia, Myanmar, Indonesia, and Timor-Leste. Liver cancer contributed the
greatest incidence and mortality in men in Cambodia, Laos, Viet Nam, and Thailand,
and was also the leading cause of death due to cancer among women in Laos,
Cambodia. and Thailand. Cervical cancer was the leading cause of death due to
cancer in women in Myanmar; colorectal cancer was the most common cancer in men
in Singapore and Brunei. By 2050, 2·03 million new cases of cancer are
anticipated in southeast Asia annually, an 89·2% increase in men and a 65·6%
increase in women, relative to 2022.The current patterns of cancer incidence
and mortality in southeast Asia are primarily driven by breast cancer in women
and lung cancer in men, but infection-related cancers (liver and cervix) are
common in some countries. Regional collaborations must be strengthened to
improve cancer prevention, diagnosis, care, and research in southeast Asia.
Read The Full Article